tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market

Kymera Therapeutics (KYMR) Income Statement

Compare
399 Followers

Kymera Therapeutics Income Statement

Last quarter (Q3 2025), Kymera Therapeutics's total revenue was $2.76M, a decrease of -26.12% from the same quarter last year. In Q3, Kymera Therapeutics's net income was $-82.17M. See Kymera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 47.07M$ 78.59M$ 46.83M$ 72.83M$ 34.03M
Gross Profit
$ 47.07M$ 78.59M$ 46.83M$ 72.83M$ 34.03M
Operating Expenses
$ 308.71M$ 244.12M$ 208.08M$ 173.36M$ 80.34M
Depreciation and Amortization
$ 7.37M$ 3.56M$ 2.98M$ 2.40M$ 1.76M
EBITDA
$ -216.24M$ -143.20M$ -151.66M$ -97.64M$ -43.72M
Operating Income
$ -261.63M$ -165.53M$ -161.26M$ -100.53M$ -46.30M
Other Income/Expenses
$ 37.78M$ 18.57M$ 6.45M$ 313.00K$ 711.00K
Pretax Income
$ -223.86M$ -146.96M$ -154.81M$ -100.22M$ -45.59M
Net Income
$ -223.86M$ -146.96M$ -154.81M$ -100.22M$ -45.59M
Per Share Metrics
Basic EPS
$ -2.98$ -2.52$ -2.87$ -2.09$ -0.99
Diluted EPS
$ -2.98$ -2.52$ -2.87$ -2.09$ -0.99
Weighted Average Shares Outstanding
75.04M 58.37M 53.93M 47.99M 44.56M
Weighted Average Shares Outstanding (Diluted)
75.04M 58.37M 53.93M 47.99M 44.56M
Currency in USD

Kymera Therapeutics Earnings and Revenue History